The Cystic Fibrosis Foundation is investing $15 million in Recode Therapeutics to advance gene-editing medicines for cystic fibrosis (CF) patients without effective treatment options.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.